Public Research Snapshot
Liminatus Pharma Inc is a publicly tracked healthcare company. This research snapshot summarizes public information on pipeline assets, clinical trials, upcoming catalysts, SEC filings, and cash runway estimates.
LIMN Stock Research Snapshot: Pipeline, Catalysts, and Cash Runway
Liminatus Pharma Inc | Needs refresh | Last updated: 2026-06-01T17:55:29Z
TickerLIMN
Market Cap8.1M
Cash RunwayRunway < 6 months
Next Catalystn/a
Pipeline
| Asset | Indication | Modality | Stage | Public Note |
|---|---|---|---|---|
| No public pipeline rows are loaded yet. | ||||
Catalyst Preview
No public catalyst rows matched this view yet.
Cash Runway Preview
Estimated cash runway: Runway < 6 months.
This is an automated estimate and may differ from company guidance.
Recent SEC Filings
- No public filing rows are loaded yet.
Clinical Trial Activity
| NCT ID | Phase | Status | Enrollment | Primary Completion |
|---|---|---|---|---|
| No public trial rows are loaded yet. | ||||
Scientific Context
- literature_publication | Lactic acid bacteria and endogenous ethanol mediate proton pump inhibitor-associated MASLD: a multicohort cross-sectional mediation analysis.
- literature_publication | Prednisolone modulates CD8⁺ and regulatory T-cell activity to dampen response to immune checkpoint inhibitor therapy in melanoma.
- literature_publication | A mixed inflammatory peripheral signature defines clinical outcomes in a phase II trial combining pembrolizumab with paclitaxel and carboplatin in melanoma.
- literature_publication | Budget impact analysis of delgocitinib for moderate to severe Chronic Hand Eczema in the United States.
- literature_publication | Treatment with low-dose bicistronic immunotherapy mitigates parasite persistence and improves serological and cardiac outcomes in adult mice infected with Trypanosoma cruzi: comparative analysis with benznidazole.
Want the full LIMN research brief?
Subscribe for source-linked catalyst analysis, cash runway monitoring, and clinical trial change alerts.
Get the weekly biotech catalyst watchlistThis page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell securities. Data may be incomplete or delayed. Cash runway and catalyst timing estimates are derived from public sources and may differ from company guidance.